2021
DOI: 10.1016/j.bioorg.2021.104969
|View full text |Cite
|
Sign up to set email alerts
|

Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
55
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 43 publications
(56 citation statements)
references
References 48 publications
1
55
0
Order By: Relevance
“…Thiazolidinedione is one of the most common classes of clinically practiced drugs for diabetes. Similarly, the succinimide is a known class of drugs for neuropharmacology and inflammation [ 44 ]. Various derivatives of succinimide-type compounds can be synthesized with different methods [ 51 54 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Thiazolidinedione is one of the most common classes of clinically practiced drugs for diabetes. Similarly, the succinimide is a known class of drugs for neuropharmacology and inflammation [ 44 ]. Various derivatives of succinimide-type compounds can be synthesized with different methods [ 51 54 ].…”
Section: Resultsmentioning
confidence: 99%
“…The experiments were repeated three times. The percent inhibitions with its subsequent IC 50 values were calculated as per the standard reported formula and were compared with the standard diclofenac [ 44 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…5I38 was obtained from the Protein Data Bank. Preparation of downloaded enzymes for binding site determination, 3-D protonation, and energy minimization was conducted as per previously reported methods [ 22 , 23 ]. Structures of the compounds were built using the builder option in the MOE software.…”
Section: Methodsmentioning
confidence: 99%
“…Recent literature survey revealed that various classes of drugs like sulfonylureas, biguanides, thiazolidinediones, and dipeptidyl peptidase-4 (dpp-4) inhibitors are used for the management of diabetes but most of these are associated with obnoxious effects [ 17 ]. Therefore we need to develop new therapeutic moieties having better efficacy and safety profiles [ 18 , 19 ].…”
Section: Introductionmentioning
confidence: 99%